We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery Services

News   May 22, 2018 | Original story from BioAscent

 
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery Services

Credit: BioAscent

 
 
Advertisement
 

RELATED ARTICLES

Prevalence of Coronavirus Antibodies Declining in England

News

Tests on more than 365,000 people in England have shown that the antibody response to the virus that causes COVID-19 wanes over time.

READ MORE

The Genetic Architecture of Penicillin Allergy

News

Researchers announce the first robust evidence for the role of the major histocompatibility complex gene HLA-B in penicillin allergy to identify genetic risk factors for penicillin allergy.

READ MORE

Scientists Knock-Out All Human Genes To Identify Which Ones SARS-CoV-2 Requires

News

To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a genome-scale, loss-of-function CRISPR screen to systematically knockout all genes in the human genome.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE